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ABSTRACT
O b jective : This study was performed to 
determine the effect of feeding with breast milk or 
formula on the serum vitamin B12 and folic acid 
levels and the urinary methyl malonic acid 
(UMMA) levels as a marker of cobalamine 
catabolism
M ateria ls and M ethods: The study group 
consisted of 42 healthy newborn infants. 
Subjects were divided into two groups. Group 1 
and 2 included 22 pre-term and 20 full-term 
neonates, respectively. The levels of B12, folic 
acid and UMMA were measured on 20th 
postnatal day in all cases. In Group 1, twelve 
infants were fed with breast milk, and the others 
with formula. Half of the infants in group 2 were 
fed with breast milk.
Results: There was no statistically significant 
difference for the levels of vitamin B12 and folic 
acid between two groups (p=0.771, p=0.371). In 
group 1, the levels of UMMA were found 30.5±9.2 
mmol MMA/mol creatinine in the breast-fed 
neonates, and 47.0±9.7 mmol MMA/mol creatinine 
in the formula-fed infants. There was a statistically 
significant difference between groups (p<0.001). 
In group 2, the levels of UMMA were found 
11,0±4.5 mmol MMA/mol creatinine in the breast­
fed neonates, and 19.0±9.5 mmol MMA/mol 
creatinine in the formula-fed neonates (p=0.001).
C o n c lu s io n : Our finding that the levels of UMMA 
in the formula-fed neonates were higher than the 
breast-fed infants suggested that breast-feeding 
has an effect of decreasing the UMMA levels.
K ey  W o rd s: Breast-feeding, Pre-term, Full- 
term, Methyl malonic acid
INTRO DUC TIO N
Recent developments in neonatology have 
caused a substantial decrease in neonatal 
mortality and morbidity. Preterm neonates or 
those with a low birthweight have often suffer 
from neurosensorial impairments, attention 
disorders and speech disorders, specific 
neuromotor disturbances, behavioral and socio- 
emotional abnormalities, and failure in school (1). 
Vitamin B12 deficiency is uncommon during 
childhood. An early diagnosis and treatment of 
this condition is important to prevent irreversible 
neurological damages. Most of the cases with 
vitamin B12 deficiency are caused by absorption 
disturbances during childhood (2).
With the exception of infants who are breast-fed 
by a vegetarian mother, the breast-fed infants 
receive about 0,3ug of vitamin B12 daily. Vitamin 
B12 is stored in the liver. Vitamin B12 is taken by
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diet in the form of hydroxycobalamine, and this 
molecule is converted to deoxyadenosyl 
cobalamine and methyl cobalamine and become 
an active coenzyme. It is metabolized through 
lysosomes by converting to methyl cobalamine or 
adenosyl cobalamine. Patients having a 
cobalamine metabolism disorder may develop 
homocystinuria and methyl malonic acidemia. 
The earliest evidences of the deficiency include a 
serum level of vitamin B12 below 100 pg/ml and 
the occurrence of hypersegmented neutrophils. 
Megaloblastic anemia, which is similar to the 
deficiency of folic acid, leukopenia and 
thrombocytopenia, occur at the later stages of 
vitamin B12 deficiency. Neurological symptoms 
may vary from peripheral neuropathy to sensorial 
signs, dementia and coma (2-4).
Vitamin B12 which must be essentially taken with 
diet has been shown to be an important factor in 
maintaining the neuronal stability in adults, and 
its deficiency has been reported to involve in the 
pathogenesis of many neuropsychiatric diseases 
such as psychosis, depression and dementia
(5,6).
The aim of this study was to assess the effect of 
feeding with breast milk or formula on the vitamin 
B12 and folic acid levels and the cobalamine 
metabolism in the full-term and pre-term 
neonates.
M ATERIAL A N D  METHODS
This study was conducted in the GMMA 
Haydarpasa Training Hospital. Twenty-two 
preterm neonates whose gestational ages were 
between 30 and 37 weeks and birthweights 
between 1300 and 2400 g (Group 1) and 20 
fullterm neonates whose birthweights between 
3000 and 4500 g (Group 2) were included in the 
study. Their parents were informed about the 
study, and gave a written consent prior to the 
study.
On the 20th postnatal day, the blood levels of 
vitamin B 12 and folic acid were measured with 
an Axym immunoassay device using the method 
of enzyme immune particle inhibition assay. The 
urinary methyl malonic acid (UMMA) levels were 
measured and calculated as the methyl malonic 
acid (MMA)/ urinary creatinine ratio with a Philips
UV/VIS Scanning device using a method of 
spectrophotometric assay on the spot urine 
sample (7), a modified form of the Giorgio and 
Plaut measurement methods (8).
For all cases, we assessed their prenatal data, 
form of labor, gestational ages, birthweights, 
status of intrauterine development, vitamins 
taken by mother, several risk factors such as 
cyanosis, apneic episodes, intracranial 
hemorrhage, hypoglycemia, hyperbilirubinemia, 
exchange transfusion, convulsion, sepsis and the 
need for ventilator, the treatment methods 
applied during the neonatal period, and the 
diseases observed throughout the study. The 
neonates who had a hereditary metabolic 
disease and congenital or chromosomal 
abnormalities were excluded from the study. 
Gestational ages were determined according to 
the date of last menstruation and using Ballard 
scoring method (9).
Students-t and Wilcoxon rank-sum tests were 
used for the statistical significance of the 
differences between two groups, with a p value 
<0.05 as an indicator of a statistically significant 
difference between the results.
RESULTS
Of the (preterm) neonates in Group 1 (n=22), 13 
(59 %) were female, and 9 (41 %) were male, 
while of the (fullterm) neonates in Group 2 
(n=20), 10 (50 %) were female, and 10 (50 %) 
were male. In Group 1, the mean birthweight and 
gestational age were found 1780±350 g and 
34.5±1.8 weeks, respectively (p<0.001). Twelve 
infants were fed with breast milk, and the others 
with formula. In Group 2, the mean birthweight 
and gestational age were found 3000±450 g and 
39.5±1.1 weeks, respectively (p<0.001). 10 
(50%) of the infants in this group, were fed with 
breast milk, and 10 (50 % ) with formula. The 
levels of vitamin B12 were 270±146 pg/ml and 
284±156 pg/ml in Group 1 and 2, respectively. 
There was no statistically significant difference in 
the levels of vitamin B12 between two groups 
(p=0.771). The levels of folic acid were found 
15±3 ng/ml and 16±4 ng/ml in Group 1 and 2, 
respectively. There was no statistically significant 
difference for the levels of folic acid between two 
groups (p=0.371).
267
A r i f  B a h a r ,  e t  al.
The urinary methyl malonic acid (UMMA) levels 
were found 38.3±12.2 mmol MMA /mol creatinine 
and 15.0±8.3 mmol MMA/ mol creatinine in 
Group 1 and 2, respectively. There was a 
statistically significant difference in the UMMA 
levels in Group 1 and 2 (p<0.001) (Table I).
T a b le  I: Characteristics of Grup-1 and Group-2
Group 1 
(Pre-term)
Group 2 
(Full-term)
P
Number 22 20
Birthweight (g)± SD 1750±350 3000±450 <0.001
Gestational age (weeks)± SD 34.5±1.8 39.5±1.1 <0.001
B12 level (pg/ml) 270±146 284*156 0.771
Folic acid level (ng/ml) 15.0±3.0 16.0±4.0 0.371
UMMA level 
(mmol/mol creatinine)
38.3i12.2 15.0*8.3 <0.001
In Group 1, the UMMA levels were found 
30.5±9.2mmol MMA/mol creatinine and 
47.0±9.7mmol MMA/mol creatinine in the breast­
fed neonates and the formula-fed neonates, 
respectively (p<0.001). In Group 2, the UMMA 
levels were found 11.0±4.5 mmol MMA/mol 
creatinine and 19.0±9.5 mmol MMA/mol 
creatinine in the breast-fed neonates and the 
formula-fed neonates, respectively (p=0.001). In 
both groups, there was statistically significant 
difference in the UMMA levels between the 
breast-fed neonates and the formula-fed 
neonates (Table II).
T ab le  II: The UMMA levels in the breast-fed neonates and 
the formula-fed neonates (mmol/mol creatinine
UMMA levels p
The breast-fed The formula-fed
Pre-term 30.5*9.2 47.0±9.7 <0.001
Full-term 11.0*4.5 19.0*9.5 0.001
P <0.001 <0.001
DISCUSSION
For the assessment of cobalamine metabolism, 
the measurement of urine methyl malonic acid or 
homocystein, which provides data for the 
metabolic or tissue level, is preferred rather than 
the measurement of serum levels (10).
An increase In the methyl malonic acid levels has 
been reported to Inhibit a mitochondrial enzyme 
succinate dehydrogenase, thus blocking the 
complex II at the respiratory chain (11,12).
In Group 1, the levels of vitamin B12 and folic 
acid were 270±146 pg/ml and 15±3 ng/ml, 
respectively; in Group 2 the levels of vitamin B12 
and folic acid were 284±156 pg/ml and 16±4 
ng/ml, respectively. These values were within the 
normal range, and there was no statistically 
significant difference between two groups 
(p>0.05). However, the finding that the UMMA 
levels were higher in the preterm infants may be 
explained by a disorder in the conversion of 
vitamin B12 into deoxy-adenosyl cobalamine or 
entering the cell, or an immature activity of these 
processes in the preterm neonates.
The finding that the UMMA levels were lower in 
the breast-fed infants than the formula-fed infants 
suggested that feeding with breast milk had an 
effect of decreasing the UMMA levels. Any 
significant increase in the UMMA levels indicates 
that methyl malonic acid leads to toxic effects on 
mitochondria, thus preparing a ground for 
possible neuropsychiatrie conditions, which may 
develop in future (2,13).
The UMMA levels-lowering effect of feeding with 
breast milk on the UMMA levels may indicate that 
a factor existing in breast milk plays a role in the 
conversion of cobalamine into its active form, or 
taking it into the cell. Studies with large series of 
cases in which the neurological developments of 
the cases are followed on a long-term basis 
should be carried out in order to clarify these 
issues. However, the data from our study could 
highlight the economical, psychological and 
immunological advantages of the breast milk as 
well as other many metabolic and neurological 
advantages that would be established in the 
future.
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